Humasis ranked among the top searched stocks on 11 days within the past month.

As of 10:30 AM on the 14th, Humasis is trading at 13,150 KRW, down 9.62% from the previous day. This represents a 23.55% decline compared to August 6. Humasis is known as an in vitro diagnostic device company.

Over the past five days, individual investors have net purchased 283,565 shares, while foreign investors and institutions have net sold 84,511 shares and net purchased 250 shares, respectively.

On August 12, Humasis became a market topic with an 8.45% increase following news of the sale of its COVID-19 diagnostic kits in the United States.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing